Cargando…
A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults
Pediatric diseases treated by allogeneic hematopoietic stem cell transplantation (alloHCT) are complex and associated with significant comorbidities and medication requirements that can complicate the transplant process. It is critical to reconcile pre-transplant concomitant medications (pcon-meds)...
Autores principales: | Apsel Winger, Beth, Long, Susie E., Brooks, Jordan, Gupta, Ashish O., Dvorak, Christopher C., Long-Boyle, Janel Renee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326409/ https://www.ncbi.nlm.nih.gov/pubmed/34350148 http://dx.doi.org/10.3389/fped.2021.713091 |
Ejemplares similares
-
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population
por: Shukla, Praveen, et al.
Publicado: (2020) -
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
por: Brooks, Jordan T., et al.
Publicado: (2022) -
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation
por: Brooks, Jordan T., et al.
Publicado: (2021) -
Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
por: Zaidman, Irina, et al.
Publicado: (2022) -
Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)